How to Cite
Abstract
Contrast-induced acute kidney injury is a very important pathology when decisions must be made in the diagnostic or therapeutic management of patients presenting renal impairment. It can be defined as a decrease in renal function that occurs hours or days after the application of contrast medium. There are risk factors related to the patient such as pre-existing renal disease, acute or chronic renal failure, diabetes mellitus, congestive heart failure or chronic hypertension. There are also other risk factors that are related to the procedure, these have to do with the type of contrast medium, amount and volume of dose. These can be modified in order to prevent the development of contrast-induced acute kidney injury. Preventive measures are the basis of the management of this pathology, currently the one with greatest scientific support is fluid therapy. While others that have been widely studied still do not have enough evidence to recommend its use.
Keywords
References
Mehran R, Dangas GD, Weisbord SD. Contrast-Associated Acute Kidney Injury. Ingelfinger JR. New England Journal of Medicine. 2019 05 30;380(22):2146-2155. https://doi.org/10.1056/nejmra1805256
Zhao F, Lei R, Yang S, Luo M, Cheng W, Xiao Y, Li X, Guo J, Duan S. Comparative effect of iso-osmolar versus low-osmolar contrast media on the incidence of contrast-induced acute kidney injury in diabetic patients: a systematic review and meta-analysis. Cancer Imaging. 2019 06 18;19(1). https://doi.org/10.1186/s40644-019-0224-6
Belinda De Simone, Luca Ansaloni, Massimo Sartelli, Federica Gaiani, Gioacchino Leandro, Gian Luigi de’Angelis et al. Is the risk of contrast-induced nephropathy a real contraindication to perform intravenous contrast enhanced Computed Tomography for non-traumatic acute abdomen in Emergency Surgery Department Acta Biomed 2018; Vol. 89, Supplement 9: 158-172 https://doi: 10.23750/abm.v89i9-S.7891
Michael R. Rudnick, Amanda K. Leonberg-Yoo, Harold I. Litt, Raphael M. Cohen,
Susan Hilton Peter P. Reese. The Controversy of Contrast-Induced Nephropathy with Intravenous Contrast: What Is the Risk? Am J Kidney Dis. 2019. https://doi: 10.1053/j.ajkd.2019.05.022
Muñoz de Bustillo Llorente E, de Miguel Balsa E. Nefropatía inducida por contrastes iodados radiológicos. Rev Clin Esp. 2018. https://doi.org/10.1016/j.rce.2018.09.004
American College of Radiology committee on drugs and contrast media, ACR manual on contrast media, version 10.3, 2018 https://www.acr.org/-/media/ACR/Files/Clinical-
Resources/Contrast_Media.pdf
Faucon A, Bobrie G, Clément O. Nephrotoxicity of iodinated contrast media: From pathophysiology to prevention strategies. European Journal of Radiology. 2019 07;116:231-241. https://doi.org/10.1016/j.ejrad.2019.03.008
Powell SP, et al, Race, contrast-induced nephropathy and long-term outcomes after coronary and peripheral angiography and intervention, Cardiovascular Revascularization Medicine (2018), https://doi.org/10.1016/j.carrev.2018.06.016
Ming-Ju Wu et al. The Predictive Value of Hyperuricemia on Renal Outcome after Contrast-Enhanced Computerized Tomography Clin. Med. 2019. https://doi:10.3390/jcm8071003
European Society of Urogenital Radiology, ESUR Guidelines on Contrast Mediav10.0, 2018. http://www.esur-cm.org/index.php/en/
Ulf Nyman, Joanna Ahlkvist, Peter Aspelin. Preventing contrast medium-induced acute kidney injury. Eur Radiol. 2018. https://doi.org/10.1007/s00330-018-5678-6
Swedish Society of Uroradiology (2017) National guidelines iodine contrast media v.6.0. Available http://www.sfmr.se/sidor/kontrastmedelsrekommendationer/.
Ibrar Anjum, Manahil Akmal, Nimra Hasnain. Statins role in preventing contrast-induced acute kidney injury: a scoping review Hong Kong Med J 2019;25:216–221
Valentina Pistolesi, Giuseppe Regolisti, Santo Morabito, Ilaria Gandolfini, Silvia Corrado, Giovanni Piotti et al. Contrast medium induced acute kidney injury: a narrative review. Jornal of Nephrology. 2018. https://doi.org/10.1007/s40620-018-0498-y
Aart J. van der Molen et al Post-contrast acute kidney injury. Part 2: risk stratification, role of hydration and other prophylactic measures, patients taking metformin and chronic dialysis patients. European Radiology. 2018. https://doi.org/10.1007/s00330-017-5247-4